Skip to main content
. 2017 Aug 4;7:7301. doi: 10.1038/s41598-017-07223-7

Table 2.

The survival and hatchability of embryos, fry survival and mutation rate of the channel catfish embryos microinjected at the one-cell stage with sgRNAs/Cas9 protein targeting the myostatin (MSTN) gene.

Treatment Embryos injected Embryo mean time to death (days) ± SEM Live embryos and Hatch Mean time to hatch (days) ± SEM Fry survival Fry mean time to death (days) ± SEM Mutated dead embryos Mutated hatched fry
N N % % % %
MSTN-1 82 6.1 ± 0.30a 44 53.7 7.2 ± 0.08b 90.9 19.0 ± 0.05 100 88.6
MSTN-2 28 4.6 ± 0.46b 7 25.0 7.0 ± 0.00ab 100 No mortality 100 100
MSTN-3 88 6.3 ± 0.22a 50 56.8 6.9 ± 0.04a 84.0 18.3 ± 0.58 100 88.0
MSTN-Mix 82 5.2 ± 0.27b 27 32.9 7.2 ± 0.08b 85.2 18.3 ± 0.81 100 96.3
iCTRL 137 6.2 ± 0.20a 83 60.6 7.1 ± 0.04b 95.2 19.6 ± 0.24
nCTRL 284 7.6 ± 0.08 220 77.5 7.4 ± 0.04 93.6 20.0 ± 0.03

Three sgRNAs were microinjected individually (MSTN-1, MSTN-2 and MSTN-3) and multiplexed (MSTN-Mix). Two controls were used; injected control embryos (iCTRL) were full-siblings to the treatment groups and were injected with the same solution and volume, but without sgRNA or Cas9 protein. The second control was not injected (nCTRL). Hatch % is the number of live embryos in each treatment divided by the total number of embryos in the same treatment and multiplied by 100. Pairwise comparisons of mean survival and hatch time were performed using Log Rank (Mantel-Cox) test with SPSS 23.0 software. All data are presented as the mean ± standard error (SEM). Means followed by different superscript letters are significantly different (p < 0.05). Mutation rates are calculated based on Surveyor analysis of all dead embryos and hatched fry.